Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

6.595 +0.045 (+0.69%)
Streaming Delayed Price Updated: 3:52 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 752,489
Open 6.450
Bid (Size) 6.590 (3)
Ask (Size) 6.600 (7)
Prev. Close 6.550
Today's Range 6.360 - 6.615
52wk Range 6.465 - 25.42
Shares Outstanding 45,047,449
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint
From Prothena Corporation plc
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga

Performance

YTD
-51.8%
-51.8%
1 Month
-30.9%
-30.9%
3 Month
-56.8%
-56.8%
6 Month
-54.3%
-54.3%
1 Year
-69.5%
-69.5%

More News

Read More
Beyond The Numbers: 7 Analysts Discuss Prothena Corp Stock
Via Benzinga
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
A Look Ahead: Prothena Corp's Earnings Forecast
Via Benzinga
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Via Benzinga
Earnings Scheduled For February 20, 2025
Via Benzinga
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
Prothena Reports First Quarter 2025 Financial Results and Business Highlights
From Prothena Corporation plc
Via Business Wire
Prothena to Report First Quarter 2025 Financial Results on May 8
From Prothena Corporation plc
Via Business Wire
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights
From Prothena Corporation plc
Via Business Wire
Demystifying Prothena Corp: Insights From 6 Analyst Reviews
Via Benzinga
Expert Ratings For Prothena Corp
Via Benzinga
Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
From Prothena Corporation plc
Via Business Wire
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Prothena Announces Board of Directors Update
From Prothena Corporation plc
Via Business Wire
Earnings Scheduled For November 12, 2024
Via Benzinga
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Prothena Catapults, Flashing A Bullish Sign, On Promise In Parkinson's Disease
Via Investor's Business Daily
Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits
Via Benzinga
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease
From Prothena Corporation plc
Via Business Wire
Prothena Reports Third Quarter 2024 Financial Results and Business Highlights
From Prothena Corporation plc
Via Business Wire

Frequently Asked Questions

Is Prothena Corporation plc - Ordinary Shares publicly traded?
Yes, Prothena Corporation plc - Ordinary Shares is publicly traded.
What exchange does Prothena Corporation plc - Ordinary Shares trade on?
Prothena Corporation plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Prothena Corporation plc - Ordinary Shares?
The ticker symbol for Prothena Corporation plc - Ordinary Shares is PRTA on the Nasdaq Stock Market
What is the current price of Prothena Corporation plc - Ordinary Shares?
The current price of Prothena Corporation plc - Ordinary Shares is 6.595
When was Prothena Corporation plc - Ordinary Shares last traded?
The last trade of Prothena Corporation plc - Ordinary Shares was at 05/23/25 03:52 PM ET
What is the market capitalization of Prothena Corporation plc - Ordinary Shares?
The market capitalization of Prothena Corporation plc - Ordinary Shares is 297.09M
How many shares of Prothena Corporation plc - Ordinary Shares are outstanding?
Prothena Corporation plc - Ordinary Shares has 297M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.